Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy

Shevach, 2011, Biological functions of regulatory T cells, Adv Immunol, 112, 137, 10.1016/B978-0-12-387827-4.00004-8 Marigo, 2008, Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells, Immunol Rev, 222, 162, 10.1111/j.1600-065X.2008.00602.x Ruffell, 2012, Differential macrophage programming in the tumor microenvironment, Trends Immunol, 33, 119, 10.1016/j.it.2011.12.001 Teng, 2010, Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth, Cancer Res, 70, 7800, 10.1158/0008-5472.CAN-10-1681 Gazzaniga, 2007, Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft, J Invest Dermatol, 127, 2031, 10.1038/sj.jid.5700827 Robinson-Smith, 2007, Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice, Cancer Res, 67, 5708, 10.1158/0008-5472.CAN-06-4375 Bates, 2006, Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse, J Clin Oncol, 24, 5373, 10.1200/JCO.2006.05.9584 Gobert, 2009, Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome, Cancer Res, 69, 2000, 10.1158/0008-5472.CAN-08-2360 Jensen, 2009, Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma, J Clin Oncol, 27, 3330, 10.1200/JCO.2008.19.9919 Medrek, 2012, The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients, BMC Cancer, 12, 306, 10.1186/1471-2407-12-306 Jensen, 2009, Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma, J Clin Oncol, 27, 4709, 10.1200/JCO.2008.18.9498 Li, 2011, Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection, J Hepatol, 54, 497, 10.1016/j.jhep.2010.07.044 Ko, 2012, HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts, J Clin Invest, 122, 3603, 10.1172/JCI62229 Nakasone, 2012, Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance, Cancer Cell, 21, 488, 10.1016/j.ccr.2012.02.017 Psaila, 2009, The metastatic niche: adapting the foreign soil, Nat Rev Cancer, 9, 285, 10.1038/nrc2621 Spano, 2012, Tumor microenvironment: a main actor in the metastasis process, Clin Exp Metastasis, 29, 381, 10.1007/s10585-012-9457-5 Sleeman, 2012, The metastatic niche and stromal progression, Cancer Metastasis Rev, 31, 429, 10.1007/s10555-012-9373-9 Minn, 2005, Genes that mediate breast cancer metastasis to lung, Nature, 436, 518, 10.1038/nature03799 Singh, 2002, Gene expression correlates of clinical prostate cancer behavior, Cancer Cell, 1, 203, 10.1016/S1535-6108(02)00030-2 van ‘t Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a Bos, 2009, Genes that mediate breast cancer metastasis to the brain, Nature, 459, 1005, 10.1038/nature08021 Koh, 2008, Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas, Oncology, 75, 92, 10.1159/000155211 Koh, 2012, Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases, Mod Pathol, 25, 828, 10.1038/modpathol.2012.32 Uno, 2006, Eradication of established tumors in mice by a combination antibody-based therapy, Nat Med, 12, 693, 10.1038/nm1405 Westwood, 2010, Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice, J Transl Med, 8, 42, 10.1186/1479-5876-8-42 Kawakami, 2013, Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions, J Immunol, 191, 3358, 10.4049/jimmunol.1300342 Lin, 2005, The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance, J Exp Med, 201, 1615, 10.1084/jem.20042307 Rivollier, 2012, Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon, J Exp Med, 209, 139, 10.1084/jem.20101387 Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J Exp Med, 176, 287, 10.1084/jem.176.1.287 Gordon, 2010, Alternative activation of macrophages: mechanism and functions, Immunity, 32, 593, 10.1016/j.immuni.2010.05.007 Peart, 2005, Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors, Proc Natl Acad Sci USA, 102, 3697, 10.1073/pnas.0500369102 Raouf, 2008, Transcriptome analysis of the normal human mammary cell commitment and differentiation process, Cell Stem Cell, 3, 109, 10.1016/j.stem.2008.05.018 Duluc, 2007, Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells, Blood, 110, 4319, 10.1182/blood-2007-02-072587 Roca, 2009, CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization, J Biol Chem, 284, 34342, 10.1074/jbc.M109.042671 Sica, 2008, Macrophage polarization in tumour progression, Semin Cancer Biol, 18, 349, 10.1016/j.semcancer.2008.03.004 Murdoch, 2008, The role of myeloid cells in the promotion of tumour angiogenesis, Nat Rev Cancer, 8, 618, 10.1038/nrc2444 Matzinger, 2011, Tissue-based class control: the other side of tolerance, Nat Rev Immunol, 11, 221, 10.1038/nri2940 Kurowska-Stolarska, 2009, IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation, J Immunol, 183, 6469, 10.4049/jimmunol.0901575 Lee, 2011, Distinct macrophage phenotypes contribute to kidney injury and repair, J Am Soc Nephrol, 22, 317, 10.1681/ASN.2009060615 Cao, 2011, IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease, J Am Soc Nephrol, 22, 1229, 10.1681/ASN.2010070693 Marabelle, 2013, Depleting tumor-specific Tregs at a single site eradicates disseminated tumors, J Clin Invest, 123, 2447, 10.1172/JCI64859 Lesokhin, 2012, Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment, Cancer Res, 72, 876, 10.1158/0008-5472.CAN-11-1792 Dalotto-Moreno, 2013, Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease, Cancer Res, 73, 1107, 10.1158/0008-5472.CAN-12-2418 Dudley, 2005, Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma, J Clin Oncol, 23, 2346, 10.1200/JCO.2005.00.240 Wolchok, 2009, Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria, Clin Cancer Res, 15, 7412, 10.1158/1078-0432.CCR-09-1624 Chang, 2001, Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy, J Immunother, 24, 88, 10.1097/00002371-200101000-00010 Daurkin, 2011, Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway, Cancer Res, 71, 6400, 10.1158/0008-5472.CAN-11-1261 Komohara, 2011, Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma, Cancer Sci, 102, 1424, 10.1111/j.1349-7006.2011.01945.x Herrera, 2013, Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients, Cancer Sci, 104, 437, 10.1111/cas.12096 Brunda, 1987, The anti-tumor effect of recombinant interferon alpha or gamma is influenced by tumor location, Int J Cancer, 40, 807, 10.1002/ijc.2910400617 Marquet, 1984, Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site, Int J Cancer, 33, 689, 10.1002/ijc.2910330521 Murphy, 1973, A murine renal cell carcinoma, J Natl Cancer Inst, 50, 1013, 10.1093/jnci/50.4.1013 Lu, 1992, Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation, Cell, 70, 153, 10.1016/0092-8674(92)90541-J